Headlines
-
Funding stymies RMMRs
Monday | Jun 3 2019REMUNERATION for the Residential Medication Management Review (RMMR) program needs to be reassessed to ensure its continued viability, according to a warning from pharmacists working in aged-care.
-
DDS celebrates 12 years
Friday | May 31 2019DISCOUNT Drug Stores (DDS) celebrated during its recent 12th national conference by highlighting an outstanding year of achievements from its franchise partners across Australia.
-
Sanofi to boost influenza vaccine supply
Thursday | May 30 2019AUSTRALIA'S influenza vaccine supply stocks are set to get a shot in the arm, after Sanofi announced it will deliver an additional 400,000 units which will arrive next week.
-
Symbion/Blooms seal deal
Thursday | May 30 2019PHARMACY wholesaler, Symbion, will retain its status as the first line supplier to the Blooms The Chemist network of pharmacies, for another five years.
-
Meds shortages threaten PBS: Guild
Wednesday | May 29 2019AUSTRALIA'S Pharmaceutical Benefits Scheme (PBS) may be under threat as a result of measures designed to protect its sustainability, Pharmacy Guild of Australia, Victorian Branch President, Anthony Tassone, (pictured) warns.
-
Medlab inks distribution deal
Wednesday | May 29 2019LISTED Australian life sciences and medicinal cannabis company, Medlab Clinical is expanding its international distribution opportunities by executing a Heads of Agreement with Thai-listed pharmaceutical company, Mega Lifesciences Public Company Limited.
-
Biosimilar savings for British Columbia
Wednesday | May 29 2019UP TO 20,400 patients receiving branded biologic drugs in the Canadian province of British Columbia will be switched to biosimilars under a new policy announced on Mon 27 May.
-
Pharmacist prescribing danger
Tuesday | May 28 2019MOVES to give pharmacists prescribing rights will compromise patient safety, a former pharmacists turned GP claims.
-
Tas hospital pharmacy win
Tuesday | May 28 2019PHARMACISTS working at Royal Hobart Hospital have received a significant funding boost, with the Tasmanian Government announcing $3.8 million for the redevelopment of the hospital's pharmacy.
-
GSK confirms vaccination shortages
Tuesday | May 28 2019GLAXOSMITHKLINE has announced that its Fluarix Tetra seasonal influenza immunisation is no longer available in the private market, with all stocks diverted to supply government programs.